Facebook pixel
Go to home page
Go to home page

New Tech for Multiple Sclerosis Diagnosis and Treatment

ScienceDaily

PATENT-PENDING TOOL CREATES 3D IMAGES OF BRAIN LESIONS
Researchers at Center for BrainHealth®, part of The University of Texas at Dallas, in collaboration with a team from UT Southwestern, have developed technology for a novel diagnostic method for multiple sclerosis (MS). The new approach has the potential to determine which damaged regions in an MS patient's brain have the capacity to heal themselves, and which do not.The researchers examined brain scans from 23 patients and 109 different lesions. Some lesions showed increased levels of surrounding oxygen, a biomarker that is known to correlate with the capacity for healing. The researchers then created 3D images of the lesions using a new, patent-pending technology tool, which revealed that the metabolically active lesions are more spherical with a rough surface, whereas the metabolically inactive lesions are irregular in shape and have a smooth surface. The results are published in the Journal of Neuroimaging (May 2019). "This diagnostic method represents a significant advance in our field, considering the new MS drugs being developed to heal damaged areas of the brain," said Dinesh Sivakolundu, the study's lead author, and a teaching and doctoral student working in Dr. Bart Rypma's lab at Center for BrainHealth. "Using our new technology, we could potentially determine which patients would benefit from such new drugs and which patients would not."The lab of Dr. Darin T. Okuda, a neurologist and MS expert with UT Southwestern Medical Center, looked at the 3D lesion images and studied lesion phenotypes to uncover the relevant biomarker: a blood oxygen level dependent (BOLD) slope that compares the amount of oxygen available at the injury site to that of its surroundings.As a result of the collaboration, the researchers were able to study MS physiology within and around lesions and its relationship to lesion physiology.“Our new technology has the potential to be a game-changer in the treatment of MS by helping doctors be more precise in their treatment plans,” added Sivakolundu. Read full story on ScienceDaily About Center for BrainHealthCenter for BrainHealth®, part of The University of Texas at Dallas, is a translational research institute committed to enhancing, preserving and restoring brain health across the lifespan. Major research areas include the use of functional and structural neuroimaging techniques to better understand the neurobiology supporting cognition and emotion in health and disease. This leading-edge scientific exploration is translated quickly into practical innovations to improve how people think, work and live, empowering people of all ages to unlock their brain potential. Translational innovations build on Strategic Memory Advanced Reasoning Tactics (SMART™), a proprietary methodology developed and tested by BrainHealth researchers and other teams over three decades.

Share this article

Bart Rypma, PhD

Principal Investigator Professor, Behavioral and Brain Sciences at UT Dallas Meadows Foundation Endowed Chair in Behavioral and Brain Sciences Director, Sammons BrainHealth Imaging Center

RELATED INFORMATION

Baseline Cerebral Metabolism Predicts Fatigue and Cognition in Multiple Sclerosis Patients

MRI technology permits non-invasive monitoring of brain oxygen metabolism, a measurement shown to be predictive of fatigue and cognitive dysfunction, common effects of multiple sclerosis.

Center for BrainHealth Advances Technique to Distinguish Brain Energy Molecules

This is the first study to clearly distinguish different energy molecules in the brain using magnetic resonance spectroscopy (MRS). The findings from this study could help to develop tests for earlier detection and intervention of Alzheimer’s disease.